Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 11;15(11):2047–2056. doi: 10.4103/1673-5374.282266

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2020 Neural Regeneration Research

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

PMC Copyright notice

Safety of PAMS treatment after MCAO.

(A) T2-weighted images of cerebral infarct volume on days 2 and 20 after MCAO. Cerebral infarct volumes in the PAMS and MCAO groups were both reduced on day 20 compared with day 2. (B) Reduction in cerebral infarct volume was not significant in the two groups on day 20 after MCAO (P > 0.05). (C) PARP, Bcl-2 and Bax expression levels. (D) No difference in PARP, Bcl-2, and Bax expression levels between the PAMS and MCAO groups (P > 0.05). Data are expressed as the mean ± SD (n = 6; independent samples t-test). MCAO: Middle cerebral artery occlusion; PAMS: paired associated magnetic stimulation.